MRCC vs PROV
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
MRCC exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a catastrophic dividend payout ratio of 1111.11%. While the stock trades at a significant discount to book value (P/B 0.66), this is a classic value trap given the negative ROE (-2.86%) and a massive YoY revenue decline of 41.80%. The combination of negative profit margins and a 0/100 technical trend suggests a continuing downward trajectory with high risk of dividend cuts.
PROV presents a classic deep-value profile, trading at a significant discount to its Graham Number ($21.04) and Intrinsic Value ($29.2). While the Piotroski F-Score of 4/9 indicates stable financial health, the company is struggling with execution, having missed earnings estimates in four consecutive quarters with an average surprise of -18.75%. Strong YoY earnings growth is currently offset by a bearish technical trend, insider selling, and high geographic concentration in Southern California real estate. The stock is fundamentally undervalued but lacks a near-term catalyst for price appreciation.
Compare Another Pair
Related Comparisons
MRCC vs PROV: Head-to-Head Comparison
This page compares Monroe Capital Corporation (MRCC) and Provident Financial Holdings, Inc. (PROV) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.